BRIEF-FDA Accepts Ascelia Pharma Type A Meeting Request

Aug 17 (Reuters) – Ascelia Pharma AB: * U.S. FOOD AND DRUG ADMINISTRATION (FDA) ACCEPTS TYPE A MEETING REQUEST TO REVIEW RESPONSE TO ORVIGLANCE NDA CRL * FDA SCHEDULES TYPE A MEETING FOR ORVIGLANCE

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)